IL6 and multiple sclerosis: MiR-455-5p is negatively correlated with the activation of the NF-κB pathway, thus inhibiting the expression of IL-1β, IL-6 and IL-8 and in turn ameliorating the severity of multiple sclerosis (Torabi et al., 2019).